Ranbaxy Drug Patent Portfolio
Ranbaxy owns 1 orange book drug protected by 1 US patent Given below is the list of Ranbaxy's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6890957 | Liquid formulation of metformin | 14 Sep, 2023 | Expired |
Latest Legal Activities on Ranbaxy's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ranbaxy.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 25 May, 2007 | US6890957 |
| Petition Entered | 29 Jan, 2007 | US6890957 |
| Post Issue Communication - Certificate of Correction Denied | 14 Dec, 2006 | US6890957 |
| Post Issue Communication - Certificate of Correction | 17 Aug, 2005 | US6890957 |
|
Recordation of Patent Grant Mailed
Critical
| 10 May, 2005 | US6890957 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 10 May, 2005 | US6890957 |
|
Issue Notification Mailed
Critical
| 20 Apr, 2005 | US6890957 |
| Receipt into Pubs | 14 Apr, 2005 | US6890957 |
| Dispatch to FDC | 13 Apr, 2005 | US6890957 |
|
Application Is Considered Ready for Issue
Critical
| 13 Apr, 2005 | US6890957 |
| Receipt into Pubs | 12 Apr, 2005 | US6890957 |
|
Issue Fee Payment Verified
Critical
| 04 Apr, 2005 | US6890957 |
|
Issue Fee Payment Received
Critical
| 04 Apr, 2005 | US6890957 |
| Workflow - File Sent to Contractor | 24 Jan, 2005 | US6890957 |
|
Mail Notice of Allowance
Critical
| 06 Jan, 2005 | US6890957 |
Ranbaxy's Family Patents
Recently granted tentative Approvals to Ranbaxy
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Ranbaxy's portfolio.
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 16 May, 2007 |
| Lamivudine | Lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 27 May, 2005 |
| Ofloxacin | Ofloxacin |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 17 Jun, 2003 |
Explore deeper patents analysis
Ranbaxy Drug List
Given below is the complete list of Ranbaxy's drugs and the patents protecting them.
1. Riomet
Riomet is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6890957 | Liquid formulation of metformin |
14 Sep, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Riomet's drug page